Historical record - last NADAC effective date: 6/19/2024

Product Information

FEVERALL 120 MG SUPPOSITORY is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $0.6987 per EA under NDC 51672211504. Its NADAC has been published 327 times since Feb 18, 2015.

FDA first approved this application before 1982.

The High Outlier badge above means this manufacturer's average price in the Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FEVERALL 120 MG SUPPOSITORY

Acetaminophen
$0.6987per EA
High Outlier
OTC

Strength

120 mg/1

NDC

51672211504

Classification

Brand

Dosage Form

SUPPOSITORY

Route

RECTAL

Effective Date

6/19/2024

Active Ingredients

ACETAMINOPHEN

Approval Type

New Drug (NDA)

FDA Application

NDA018337

FDA Approved

Before 1982

On Market Since

12/12/2013

Price Statistics

The NADAC for FEVERALL 120 MG SUPPOSITORY has been published 327 times since Feb 18, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.6987 per EA
All-time high$0.7997 (Apr 15, 2015)
All-time low$0.6803 (Apr 19, 2017)
Median price$0.7150
Average price$0.7165
Largest weekly change+13.6% (Mar 18, 2015)
Weeks tracked327
Tracking sinceFeb 18, 2015

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+1.0%

5Y

+1.0%

All

-0.8%

Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of FEVERALL 120 MG SUPPOSITORY?

The current National Average Drug Acquisition Cost (NADAC) for FEVERALL 120 MG SUPPOSITORY, manufactured by Sun Pharmaceutical Industries Inc., is $0.6987 per EA (NDC 51672211504), effective Aug 14, 2024.

How has the price of FEVERALL 120 MG SUPPOSITORY changed over time?

Over the history we have for it, the NADAC for FEVERALL 120 MG SUPPOSITORY has held within roughly two percent of its current level. It has been tracked across 327 weekly CMS publications since Feb 18, 2015.

What are the highest and lowest recorded NADAC prices for FEVERALL 120 MG SUPPOSITORY?

Since Feb 18, 2015, the NADAC for FEVERALL 120 MG SUPPOSITORY has ranged from a low of $0.6803 (Apr 19, 2017) to a high of $0.7997 (Apr 15, 2015), with a median of $0.7150 per EA.

Are there cheaper alternatives to FEVERALL 120 MG SUPPOSITORY?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAMINOPHEN 120 MG SUPPOS, is $0.2442 per EA — about 65% below FEVERALL 120 MG SUPPOSITORY.

Who manufactures FEVERALL 120 MG SUPPOSITORY?

FEVERALL 120 MG SUPPOSITORY (NDC 51672211504) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.